Akums Drugs and Pharmaceuticals Limited
ICICI Prudential Mutual Fund decreased its stake in Akums Drugs and Pharmaceuticals from 4.56% to 3.14% by selling 22,33,269 shares. This is a partial exit.
A contract development and manufacturing organization that produces pharmaceutical products for domestic and international clients. Established in 2004, Akums Drugs operates across multiple therapeutic areas and dosage forms, providing end-to-end manufacturing solutions including formulation development, clinical trial supplies, and commercial production. The company distinguishes itself through its vertically integrated operations, modern manufacturing facilities, and commitment to quality compliance across all operations.
India's second-largest AMC by AUM with over Rs 9 lakh crore managed across 80+ schemes. Joint venture between ICICI Bank and Prudential plc. CIO S. Naren is one of India's most recognised value investors, known for contrarian macro calls and rotating across market caps well ahead of consensus. ICICI Pru's quarterly portfolio disclosures are among the most closely watched in the industry.